Tags : Melanie Huber

Appointments

Kellerhals Carrard partners and counsels appointments for 2022  

Kellerhals Carrard has announced the appointment of eight new partner and three new counsels.    Meet the new partners  Martin Föhse first joined Kellerhals Carrard in 2015. He specialises in constitutional and administrative law. He advises companies, federal, cantonal and municipal authorities as well as private individuals, also as an representative in court proceedings and in […]

Deal & transactions

Katadyn Group acquired by a group of entre­pren­eurs led by Kontivia

Katadyn Group, a Swiss-based spe­cial­ist in port­able water fil­ters and trekking food, has been acquired by a group of entre­pren­eurs led by Kontivia, a long-term, down-to-earth investment company and invests together with selected entrepreneurial families in established medium- sized companies in Switzerland and southern Germany. The acquisition was consummated through Bifolia Holding which was renamed in Katadyn Group following the closing of the transaction.  The majority shareholder of Katadyn Holding, Adrian Schmassmann, and […]

Deal & transactions

Helix Acquisition Corp business agreement with MoonLake. The advisors

Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At closing of the envisaged business combination, MoonLake will have access to approximately USD 230 million in cash (subject to redemptions), […]

Banking & Finance

MoonLake Immunotherapeutics closes Series A Funding Round – The Advisors

MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseaseshas closed a Series A financing round, lead by BVF Partners LP. Other investors included Merck KGaA, Darmstadt, Germany. MoonLake Immunotherapeutics was established by an international team of immunology specialists to create next-level therapies for inflammatory skin and joint […]